Markets
← Back to Stocks
GEHC
GE HEALTHCARE TECHNOLOGY
Health Care · Health Care Equipment
$70.37
-0.03%
Vol: 0.1M
Araverus Market Read
Thursday, March 19, 2026
GE HealthCare beats Q4 EPS, FDA clearances for MR innovations boost growth
GE HealthCare reported adjusted earnings $1.44 per share, beating consensus $1.40, with annual profit forecast above Wall Street estimates. Company received FDA 510(k) clearances for three next-generation MR innovations and launched ReadyFix remote fleet management solution in February 2026. Stock at $70.33 with Buy consensus rating and $93.05 12-month target.
Price 50d 200d
Previous Market Reads
2 of 2 daysSector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$32.1B
P/E (TTM)15.5
Forward P/E12.6
Beta1.18
Div Yield20.00%
Prev Close$70.39
RSI (14-Day)
19Oversold
0305070100
52-Week Range
$57.65$70.37$89.77
From High-21.6%
From Low+22.1%
Moving Averages
50d SMA
$79.81-11.8%
200d SMA
$76.86-8.4%
Price below 200d MA — bearish structure.
Returns
1W
+0.1%
1M
-15.2%
3M
-14.4%
6M
-8.1%
1Y
-14.2%
YTD
-15.0%
Volume
Today102K
20d Avg3.4M
Ratio0.03x